Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Borstkanker"'
Publikováno v:
Leenders, M W H 2023, ' The evolution of axillary staging in breast cancer ', PhD, Vrije Universiteit Amsterdam . https://doi.org/10.5463/thesis.195
PART 1 of the thesis presents two studies that evaluate accuracy of radiological modalities to select breast cancer patients with (one or more) positive axillary nodes. Although several recent randomised studies demonstrated that omitting cALND in se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4612::aa6ac0bce4ed5ce557ae39e203e272e1
https://hdl.handle.net/1871.1/70d80dd9-3fc5-419f-9a99-47495a612d37
https://hdl.handle.net/1871.1/70d80dd9-3fc5-419f-9a99-47495a612d37
PART 1 of the thesis presents two studies that evaluate accuracy of radiological modalities to select breast cancer patients with (one or more) positive axillary nodes. Although several recent randomised studies demonstrated that omitting cALND in se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4612::af4ede8eb4b92460a64b3ef2b33097ba
https://research.vu.nl/en/publications/70d80dd9-3fc5-419f-9a99-47495a612d37
https://research.vu.nl/en/publications/70d80dd9-3fc5-419f-9a99-47495a612d37
Autor:
Schrijver, Lieske Heleen
Publikováno v:
Schrijver, L H 2022, ' Hormonal modifiers of breast and ovarian cancer risk in BRCA1/2 mutation carriers ', PhD, Vrije Universiteit Amsterdam, Amsterdam .
Women who carry a pathogenic variant (mutation) in the BRCA1 or BRCA2 genes have a high lifetime risk of breast and ovarian cancer. The high lifetime breast and ovarian cancer risks among BRCA1 and BRCA2 mutation carriers shows a wide variation. Know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2fdba37da2107fc79940897a204bb626
https://research.vu.nl/en/publications/32faae24-1a32-44cd-acfe-4ed808333951
https://research.vu.nl/en/publications/32faae24-1a32-44cd-acfe-4ed808333951
Breast cancer is a major public health concern, in the Netherlands, 1 in 7 women are diagnosed with breast cancer in their lifetime. In women receiving chemotherapy, weight gain and undesirable changes in body composition is a common but poorly under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4612::d362d7c950c37294c107b5323f372469
https://doi.org/10.5463/thesis.46
https://doi.org/10.5463/thesis.46
Publikováno v:
de Kruif, J T C M 2023, ' The impact of breast cancer diagnosis and treatment on body weight and weight-related lifestyle : Qualitative and mixed-methods studies in women with breast cancer and their healthcare professionals ', PhD, Vrije Universiteit Amsterdam, Niftrik . https://doi.org/10.5463/thesis.46
Breast cancer is a major public health concern, in the Netherlands, 1 in 7 women are diagnosed with breast cancer in their lifetime. In women receiving chemotherapy, weight gain and undesirable changes in body composition is a common but poorly under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::efdb23e021b8f896e5627ef2c89042c2
https://doi.org/10.5463/thesis.46
https://doi.org/10.5463/thesis.46
Women who carry a pathogenic variant (mutation) in the BRCA1 or BRCA2 genes have a high lifetime risk of breast and ovarian cancer. The high lifetime breast and ovarian cancer risks among BRCA1 and BRCA2 mutation carriers shows a wide variation. Know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4612::9bf051901e1a6125af6f05ef20f616be
https://research.vu.nl/en/publications/32faae24-1a32-44cd-acfe-4ed808333951
https://research.vu.nl/en/publications/32faae24-1a32-44cd-acfe-4ed808333951
Autor:
Sprangers, W.
Dit onderzoek richt zich op het vinden van argumenten waarom het wel of niet zinvol is om patiënten te betrekken bij de ontwikkeling van voorlichtingsmateriaal. Dit fenomeen is onderzocht in een topklinisch ziekenhuis voor de operatieve behandeling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4301::839d1fdb90ebcf2599e774016f250717
https://research.ou.nl/ws/files/41289787/Sprangers_W_IM9806_AF_BPMIT_scriptie_PURE.pdf
https://research.ou.nl/ws/files/41289787/Sprangers_W_IM9806_AF_BPMIT_scriptie_PURE.pdf
Autor:
Stéphanie Vera de Lange
In the Dutch breast cancer screening program, all women aged 50 to 75 years are invited for mammography screening biennially. Yearly, approximately 1 million screening examinations are performed in the screening program. Approximately 8% of the Dutch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e60c3d9461f6eadb6d7c86e6603ef3
https://dspace.library.uu.nl/handle/1874/400291
https://dspace.library.uu.nl/handle/1874/400291
Autor:
Carmen van Dooijeweert
Breast cancer treatment is largely guided by the results of tumor tissue analyses, i.e. evaluation of so called biomarkers, by pathologists. These biomarkers determine whether the tumor is sensitive to treatment with hormone therapy or treatment agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9dc09db215efbca1a90e58fff8c96dd
https://dspace.library.uu.nl/handle/1874/399517
https://dspace.library.uu.nl/handle/1874/399517
Autor:
Coutinho, Sophie
Publikováno v:
VIP Science: wetenschappelijk magazine voor verpleegkundigen in het Erasmus MC, mei 2020(10), 4-5
Eind augustus 2019 studeerde Sophie Coutinho af als verpleegkundig specialist. Haar afstudeeronderzoek werd gekozen tot beste afstudeeronderzoek, daarmee won ze de zogenaamde ‘mastertheseprijs’ van de Hogeschool Rotterdam.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d11130a1796b1ca42546b1ae4ae2977a
https://surfsharekit.nl/public/e5b73930-fa6a-4341-b553-0b2c08ed3c28
https://surfsharekit.nl/public/e5b73930-fa6a-4341-b553-0b2c08ed3c28